ArticleJournal of neurology2023

Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing-remitting multiple sclerosis patients: a monocentric longitudinal observational study.

Chiara Zanetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.